CTLA4 and colitis: We extracted data pertaining to the 3 CD8+ TRM cell populations (Figure 6H) and found that the CD8+ TRM cell population 2, comprised mostly cells from patients with PD-1 colitis, has markedly high expression of activation markers (HLADR, CD38) and checkpoint molecules (CTLA4, TIM3).